Literature DB >> 30546535

Diagnosing burned-out hypertrophic cardiomyopathy: Daughter's phenotype solidifies father's diagnosis.

George Rahmani1, Greg Kraushaar2, Payam Dehghani2.   

Abstract

Patients with hypertrophic cardiomyopathy classically have preserved systolic function in the setting of impaired diastolic function and decreased left ventricular end-diastolic volume. However, in a small sub-population, patients paradoxically develop systolic dysfunction, left ventricular dilatation, and ventricular wall thinning. This pattern is one that is likened to dilated cardiomyopathy and is known as end-stage hypertrophic cardiomyopathy or "burned-out cardiomyopathy." The role of cardiac magnetic resonance imaging is well defined in narrowing the differential diagnosis of impaired left ventricular function, including that of hypertrophic cardiomyopathy. However, the importance of obtaining a family history and obtaining details of diagnosis for both preceding and future generations cannot be under-estimated. We report a case of end-stage hypertrophic cardiomyopathy that highlights how important family history can be in making a diagnosis. <Learning objective: While most cases of burned-out hypertrophic cardiomyopathy occur long after a patient has been initially seen and subsequently followed by cardiologists for hypertrophic cardiomyopathy, a small proportion of patients initially present with this entity. This is one such case, and it highlights the importance of thorough investigation into a patient's family history.>.

Entities:  

Keywords:  Burned-out cardiomyopathy; Cardiac magnetic resonance imaging; Hypertrophic cardiomyopathy

Year:  2014        PMID: 30546535      PMCID: PMC6279988          DOI: 10.1016/j.jccase.2014.10.010

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  12 in total

1.  Images in cardiovascular medicine. Hypertrophic cardiomyopathy in monozygotic twins.

Authors:  Barry J Maron; Susan A Casey; Adrian K Almquist
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

2.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

3.  Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.

Authors:  I Olivotto; F Cecchi; S A Casey; A Dolara; J H Traverse; B J Maron
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

Review 4.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  Reversal of dilated to hypertrophic cardiomyopathy after alcohol abstinence.

Authors:  C Stöllberger; J Finsterer
Journal:  Clin Cardiol       Date:  1998-05       Impact factor: 2.882

6.  A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy.

Authors:  Noboru Fujino; Masami Shimizu; Hidekazu Ino; Masato Yamaguchi; Toshihiko Yasuda; Mitsuru Nagata; Tetsuo Konno; Hiroshi Mabuchi
Journal:  Am J Cardiol       Date:  2002-01-01       Impact factor: 2.778

7.  Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.

Authors:  Elena Biagini; Fabio Coccolo; Marinella Ferlito; Enrica Perugini; Guido Rocchi; Letizia Bacchi-Reggiani; Carla Lofiego; Giuseppe Boriani; Daniela Prandstraller; Fernando M Picchio; Angelo Branzi; Claudio Rapezzi
Journal:  J Am Coll Cardiol       Date:  2005-09-28       Impact factor: 24.094

8.  Images in cardiovascular medicine. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy.

Authors:  Barry J Maron; Tammy S Haas; John R Lesser
Journal:  Circulation       Date:  2007-06-19       Impact factor: 29.690

9.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

10.  Morphologic evidence for "small vessel disease" in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; S E Epstein; W C Roberts
Journal:  Z Kardiol       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.